Clinical Trials at Memorial Sloan Kettering Cancer Center (All Protocol Activities)
As of September 2026, 147 paid clinical trials are recruiting at Memorial Sloan Kettering Cancer Center (All Protocol Activities), located at 1275 YORK AVE, MEMORIAL 7, NEW YORK, NY 10065-6007, phone (212) 639-2000 in New York, New York. Active studies at this site cover conditions such as Breast Cancer, Prostate Cancer and Multiple Myeloma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in New York
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
149 clinical trials at Memorial Sloan Kettering Cancer Center (All Protocol Activities)
·Clear filters·A Study of a Side Effects and Resource Navigation Program for People With Cancer
A Study of CRD3874-SI in People With Leukemia
A Study of a Urine Test to Detect Colorectal Cancer
A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
A Study of Methylprednisolone in People Having Liver Surgery
A Dietary Study for People With Clonal Hematopoiesis
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
A Study of Mirdametinib in People With Central Nervous System Tumors
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Registry for Bone Metastases
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
A Study of Revumenib and Mezigdomide in People With Leukemia
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain
Registry Study of People Who Are Having an Esophagectomy and Are at High Risk of Anastomotic Leak
A Study of Tarlatamab for People With Prostate Cancer
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
A Registry for People With Lung Cancer
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
A Study of 177Lu-PSMA-617 in People With Gliomas
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast Cancer
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Common conditions studied in New York
- Breast Cancer (92 active studies)
- Prostate Cancer (74 active studies)
- Multiple Myeloma (44 active studies)
- Colorectal Cancer (42 active studies)
- Ovarian Cancer (41 active studies)
- Endometrial Cancer (37 active studies)
Leading research sponsors in New York
- Memorial Sloan Kettering Cancer Center
- NYU Langone Health
- Columbia University
- Icahn School of Medicine at Mount Sinai
- Weill Medical College of Cornell University
Frequently asked questions
How many paid clinical trials are currently recruiting in New York?
There are approximately 3,375 recruiting clinical trials in New York, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in New York pay participants?
Most recruiting trials in New York compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in New York?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in New York?
The most common conditions under active study in New York include Breast Cancer (92), Prostate Cancer (74), Multiple Myeloma (44), Colorectal Cancer (42), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in New York?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New York on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in New York?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in New York?
Recruiting research sites in New York include Memorial Sloan Kettering Cancer Center, NYU Langone Health, Icahn School of Medicine at Mount Sinai, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in New York right now?
The largest active categories in New York are Cancer & tumors (1,129), Neurology & pain (198), Cardiovascular (195). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Memorial Sloan Kettering Cancer Center (All Protocol Activities)?
Memorial Sloan Kettering Cancer Center (All Protocol Activities) is located at 1275 YORK AVE, MEMORIAL 7, NEW YORK, NY 10065-6007. Use the Google Maps link in the intro above to get directions.
How do I contact Memorial Sloan Kettering Cancer Center (All Protocol Activities)?
You can reach Memorial Sloan Kettering Cancer Center (All Protocol Activities) by phone at (212) 639-2000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.